根治性前列腺切除术的效应估计:整合SPCG4与PIVOT随机试验数据及当代队列
该研究比较根治性前列腺切除术与保守治疗对局限性前列腺癌死亡率的影响,整合SPCG4和PIVOT随机试验数据及当代队列。结果显示手术相对风险不随基线风险变化,GG1患者15年死亡率降低仅0.2%,GG2低PSA/分期患者≤5%,GG3或GG4患者为6%-9%但效应估计范围宽(6%-36%)。作者认为低危(GG1)及许多GG2患者应避免手术,高危患者手术获益更大。
要点
- 手术相对风险不随基线风险变化,支持使用恒定相对风险。
- GG1患者手术15年死亡率降低仅0.2%,GG2低PSA/分期患者≤5%。
- GG3或GG4患者手术获益6%-9%,但效应估计范围宽达6%-36%。
核心结论
- 作者认为低危(GG1)前列腺癌及许多GG2患者应避免手术,高危患者手术获益更大。
- 将研究结果与预期寿命模型整合,可帮助患者根据肿瘤风险、其他原因死亡风险和手术估计效应做出知情治疗决策。
研究设计与样本
- 研究整合SPCG4和PIVOT两项随机试验数据与当代队列,开发个体化预测模型比较立即手术与主动监测。
- 研究先判断手术vs观察的前列腺癌死亡相对风险是否随基线风险变化,再用不同相对风险估计值结合生化复发风险模型预测15年死亡率。
主要发现
- 未发现相对风险随基线风险变化的证据,支持使用恒定相对风险。
- 与观察相比,GG1患者手术15年死亡率降低0.2%,GG2低PSA/分期患者降低≤5%。
- GG3或GG4患者手术获益6%-9%,但效应估计范围宽,取决于手术风险比选择,绝对风险降低为6%-36%。
临床怎么用
- 作者认为低危(GG1)及许多GG2患者应避免手术,高危患者手术获益更大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Two randomized trials (SPCG4 and PIVOT) have compared surgery to conservative management for localized prostate cancer. The applicability of these trials to contemporary practice remains uncertain. We aimed to develop an individualized prediction model for prostate cancer mortality comparing immediate surgery at a high-volume center to active surveillance. MATERIALS AND METHODS: We determined whether the relative risk of prostate cancer mortality with surgery vs observation varied by baseline risk. We then used various estimates of relative risk to estimate 15-year mortality with and without surgery using, as a predictor, risk of biochemical recurrence calculated from a model. RESULTS: We saw no evidence that relative risk varied by baseline risk, supporting the use of a constant relative risk. Compared with observation, surgery was associated with negligible benefit for patients with Grade Group (GG) 1 disease (0.2% mortality reduction at 15 years) and small benefit for patients with GG2 with lower PSA and stage (≤5% mortality reduction). Benefit was greater (6%-9%) for patients with GG3 or GG4 though still modest, but effect estimates varied widely depending on choice of hazard ratio for surgery (6%-36% absolute risk reduction). CONCLUSIONS: Surgery should be avoided for men with low-risk (GG1) prostate cancer and for many men with GG2 disease. Surgical benefits are greater in men with higher-risk disease. Integration of findings with a life expectancy model will allow patients to make informed treatment decisions given their oncologic risk, risk of death from other causes, and estimated effects of surgery.
引用
- Vickers A, Vertosick E, Langsetmo L, et al. Estimating the Effect of Radical Prostatectomy: Combining Data From the SPCG4 and PIVOT Randomized Trials With Contemporary Cohorts. J Urol. 2024. PMID: 38865734. doi:10.1097/JU.0000000000004039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。